E3 PreliminaryPreliminaryPEM unclearMechanisticPeer-reviewedReviewed
Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lv, Yongbiao, Zhang, Tian, Cai, Junxiang et al. · Frontiers in immunology · 2022 · DOI
Quick Summary
Researchers compared the genes involved in Long COVID (lasting symptoms after COVID-19 infection) and ME/CFS to see if they share common biological causes. They found 9 genes that appear in both conditions and identified five key proteins that may be driving the shared symptoms. The study suggests these conditions may have overlapping mechanisms, pointing toward potential new treatments worth testing in future research.
Why It Matters
This study provides evidence that Long COVID and ME/CFS may share underlying biological mechanisms, which could explain why many COVID-19 patients develop ME/CFS-like symptoms. Identifying common molecular pathways offers a foundation for developing treatments that could benefit both conditions, and the predicted drug candidates provide specific leads for experimental testing.
Observed Findings
- Nine genes identified as common to both Long COVID and ME/CFS
- Five hub proteins highlighted through protein interaction network analysis: IL-6, IL-1B, CD8A, TP53, and CXCL8
- Gene enrichment analysis revealed biological pathways associated with inflammation and immune dysfunction
- Ten potential chemical compounds computationally predicted as candidate therapeutics
- Transcription factor-gene and transcription factor-miRNA networks mapped for both conditions
Inferred Conclusions
- Long COVID and ME/CFS likely share overlapping biological mechanisms involving immune dysfunction and inflammation
- The identified hub proteins may represent key therapeutic targets for treating both conditions
- Computationally predicted drugs warrant experimental validation as potential treatments
- Common gene networks suggest a potential pathogenic link between post-viral syndromes and ME/CFS
Remaining Questions
- Do the nine identified genes actually contribute to disease pathogenesis, or are they merely correlated with the conditions?
- Which of the ten predicted drug candidates would be most effective and safe in animal or human studies?
What This Study Does Not Prove
This computational study does not prove that the identified genes actually cause Long COVID or ME/CFS—it identifies statistical associations and predicts pathways based on existing data. The predicted drug candidates have not been tested in laboratory or clinical settings, so efficacy remains entirely theoretical. The findings do not establish whether Long COVID and ME/CFS are identical conditions or merely share some overlapping features.
Tags
Symptom:Fatigue
Biomarker:CytokinesGene ExpressionBlood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- DOI
- 10.3389/fimmu.2022.952987
- PMID
- 36189286
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.